“Adherence and Identification of Access Barriers in Patients With Autoimmune Diseases Treated With an Adalimumab Biosimilar in Colombia”. Universitas Scientiarum, Oct. 2025, p. S17, https://doi.org/10.11144/Javeriana.SCSI30.aaio.